VVC-U of Iowa-1339

FIV3.2mU6miSafeCMVeGFP VSVG

  • $651.00


FIV vector with Mouse U6 Promoter driving a scrambled miRNA control miSafe cassette followed by a second reporter cassette containing the CMV (Cytomegalovirus) Promoter driving EGFP. VSVG envelope. Please reference: Boudreau, R. L., et al. (2011). "Rational Design of Therapeutic siRNAs: Minimizing Off-targeting Potential to Improve the Safety of RNAi Therapy for Huntington's Disease." Mol Ther 19(12): 2169-2177. 

*Discounts may apply to non-profit customers